Five Substitutions in Dolichol Kinase that Cause Congenital Defects in Glycosylation and Dilated Cardiomyopathy
Introduction:
Dolichol kinase (DOLK) plays a crucial role in protein glycosylation, and mutations in this gene can cause congenital disorders of glycosylation (CDG), resulting in multi-systemic effects, including severe heart issues like dilated cardiomyopathy (DCM). The following cases highlight five key DOLK substitutions associated with congenital defects, identified and compiled using Adenine AI, a tool that helps find genetic evidence for clinical application.
DOLK:c.1342G>A (p.Gly448Arg) and DOLK:c.1558A>G (p.Thr520Ala)
DOLK:c.1447C>A (p.Gln483Lys)
DOLK:c.1222C>G (p.His408Asp)
DOLK:c.912G>T (p.Trp304Cys)
DOLK:c.912G>T (p.Trp304Cys)
Conclusion:
These five DOLK substitutions demonstrate the diverse clinical outcomes associated with CDG, from neonatal ichthyosis to dilated cardiomyopathy in older children. Early identification and genetic diagnosis are essential for managing these severe disorders. While Adenine AI doesn't provide testing, it supports clinicians in quickly gathering the genetic evidence needed for effective diagnosis and treatment planning.